.: ORİJİNAL ARAŞTIRMA
COVID-19 Vaccine Hesitancy in Pregnant Women and Affecting Factors: Cross-Sectional Study
Gebelerin COVID-19 Aşı Karşıtlığı ve Etkileyen Faktörler: Kesitsel Bir Araştırma
Turkiye Klinikleri J Health Sci. 2023;8(4):593-603
doi: 10.5336/healthsci.2023-97440
Makale Dili: EN
Tam Metin
ABSTRACT
Objective: The severe acute respiratory syndrome-coronavirus-2 virus is transmitted from person to person through contact, droplets, and airborne particles. The vaccine is effective in controlling the coronavirus disease-2019 (COVID-19) pandemic. Pregnant women due to changes in their bodies are vulnerable to infectious diseases, some of which can be prevented by vaccination. This study, it was aimed to examine the hesitancy of the COVID-19 vaccine in pregnant women and the factors affecting it. Material and Methods: The population of this cross-sectional study consisted of all pregnant women aged 15-49 years who applied to Mardin Training and Research Hospital. The convenience sampling method was used in the study, and all pregnant women (n=211) who applied to the hospital between October 10, 2022- December 23, 2022, met the inclusion criteria and agreed to participate in the study constituted the sample of the study. The data was collected using the ''questionnaire form'' and the ''Vaccine Hesitancy Scale.'' Cronbach alpha value of the scale was found to be 0.790. and the total mean score was found to be 61.24±11.63 it was determined that the pregnant women had a ''moderate'' level of hesitancy to vaccination. Results: It has been concluded that the husband's education status, the gestation week, the number of pregnancies, the presence of chronic patients in the household, and the history of abortion were effective on the vaccine hesitancy in the pregnant woman. Conclusion: Pregnant women should be informed more about vaccination and encouraged to be vaccinated. More studies on the subject are needed.
Keywords: COVID-19 vaccine; pregnant women; vaccination hesitancy
Objective: The severe acute respiratory syndrome-coronavirus-2 virus is transmitted from person to person through contact, droplets, and airborne particles. The vaccine is effective in controlling the coronavirus disease-2019 (COVID-19) pandemic. Pregnant women due to changes in their bodies are vulnerable to infectious diseases, some of which can be prevented by vaccination. This study, it was aimed to examine the hesitancy of the COVID-19 vaccine in pregnant women and the factors affecting it. Material and Methods: The population of this cross-sectional study consisted of all pregnant women aged 15-49 years who applied to Mardin Training and Research Hospital. The convenience sampling method was used in the study, and all pregnant women (n=211) who applied to the hospital between October 10, 2022- December 23, 2022, met the inclusion criteria and agreed to participate in the study constituted the sample of the study. The data was collected using the ''questionnaire form'' and the ''Vaccine Hesitancy Scale.'' Cronbach alpha value of the scale was found to be 0.790. and the total mean score was found to be 61.24±11.63 it was determined that the pregnant women had a ''moderate'' level of hesitancy to vaccination. Results: It has been concluded that the husband's education status, the gestation week, the number of pregnancies, the presence of chronic patients in the household, and the history of abortion were effective on the vaccine hesitancy in the pregnant woman. Conclusion: Pregnant women should be informed more about vaccination and encouraged to be vaccinated. More studies on the subject are needed.
Keywords: COVID-19 vaccine; pregnant women; vaccination hesitancy
ÖZET
Amaç: Şiddetli akut solunum sendromu-koronavirüs-2 virüsü, insandan insana temas, damlacık ve havada asılı partiküller yoluyla bulaşmaktadır. Aşı, koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisini kontrol altına almada etkilidir. Gebeler vücutlarında meydana gelen değişiklikler nedeniyle, bazıları aşı ile önlenebilen bulaşıcı hastalıklarda savunmasız bir gruptur. Bu çalışmada, gebelerin COVID-19 aşı karşıtlığı ve etkileyen faktörleri incelemek amaçlanmıştır. Gereç ve Yöntemler: Kesitsel tipte olan bu çalışmanın evrenini Mardin Eğitim ve Araştırma Hastanesine başvuran 15-49 yaş aralığındaki tüm gebeler oluşturmaktadır. Çalışmada kolayda örnekleme yöntemi kullanılmış olup, 10 Ekim 2022-23 Aralık 2022 tarihleri arasında hastaneye başvuran, çalışmaya dâhil edilme kriterlerini karşılayan ve çalışmaya katılmayı kabul eden tüm gebeler (n=211) araştırmanın örneklemini oluşturmuştur. Veriler ''anket formu'' ve ''Aşı Karşıtlığı Ölçeği'' kullanılarak toplanmıştır. Ölçeğin Cronbach alfa değeri 0,790, toplam puan ortalaması 61,24±11,63 olarak bulunmuştur ve gebelerin aşı karşıtlığının ''orta'' düzeyde olduğu belirlenmiştir. Bulgular: Eş eğitim durumu, gebelik haftası, gebelik sayısı, hanede kronik hasta varlığı ve abortus öyküsünün gebelerde aşı karşıtlığı üzerinde etkili olduğu sonucuna varılmıştır. Sonuç: Gebelerin aşı konusunda daha çok bilgilendirilmeleri ve aşıya teşviklerinin sağlanması gerekmektedir. Konu ile ilgili daha çok çalışmaya ihtiyaç duyulmaktadır.
Anahtar Kelimeler: COVID-19 aşıları; gebe kadınlar; aşı karşıtlığı
Amaç: Şiddetli akut solunum sendromu-koronavirüs-2 virüsü, insandan insana temas, damlacık ve havada asılı partiküller yoluyla bulaşmaktadır. Aşı, koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisini kontrol altına almada etkilidir. Gebeler vücutlarında meydana gelen değişiklikler nedeniyle, bazıları aşı ile önlenebilen bulaşıcı hastalıklarda savunmasız bir gruptur. Bu çalışmada, gebelerin COVID-19 aşı karşıtlığı ve etkileyen faktörleri incelemek amaçlanmıştır. Gereç ve Yöntemler: Kesitsel tipte olan bu çalışmanın evrenini Mardin Eğitim ve Araştırma Hastanesine başvuran 15-49 yaş aralığındaki tüm gebeler oluşturmaktadır. Çalışmada kolayda örnekleme yöntemi kullanılmış olup, 10 Ekim 2022-23 Aralık 2022 tarihleri arasında hastaneye başvuran, çalışmaya dâhil edilme kriterlerini karşılayan ve çalışmaya katılmayı kabul eden tüm gebeler (n=211) araştırmanın örneklemini oluşturmuştur. Veriler ''anket formu'' ve ''Aşı Karşıtlığı Ölçeği'' kullanılarak toplanmıştır. Ölçeğin Cronbach alfa değeri 0,790, toplam puan ortalaması 61,24±11,63 olarak bulunmuştur ve gebelerin aşı karşıtlığının ''orta'' düzeyde olduğu belirlenmiştir. Bulgular: Eş eğitim durumu, gebelik haftası, gebelik sayısı, hanede kronik hasta varlığı ve abortus öyküsünün gebelerde aşı karşıtlığı üzerinde etkili olduğu sonucuna varılmıştır. Sonuç: Gebelerin aşı konusunda daha çok bilgilendirilmeleri ve aşıya teşviklerinin sağlanması gerekmektedir. Konu ile ilgili daha çok çalışmaya ihtiyaç duyulmaktadır.
Anahtar Kelimeler: COVID-19 aşıları; gebe kadınlar; aşı karşıtlığı
REFERANSLAR:
- Badell ML, Dude CM, Rasmussen SA, Jamieson DJ. Covid-19 vaccination in pregnancy. BMJ. 2022;378:e069741. [Crossref] [PubMed] [PMC]
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60. [PubMed] [PMC]
- World Health Organization [Internet]. [Cited: February 1, 2023]. WHO coronavirus (Covid-19) dashboard. 2023. Available from: [Link]
- Maternal-Fetal Tıp ve Perinatoloji Derneği. Gebelerde ve emziren annelerde covid-19 aşıları ile ilgili Türkiye Maternal-Fetal Tıp ve Perinatoloji Derneği Görüşü. 2021. [Erişim tarihi: 16.01.2023]. Erişim linki: [Link]
- Bianchi FP, Stefanizzi P, Di Gioia MC, Brescia N, Lattanzio S, Tafuri S. COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21(10):1443-54. [Crossref] [PubMed]
- Sakala IG, Honda-Okubo Y, Fung J, Petrovsky N. Influenza immunization during pregnancy: Benefits for mother and infant. Hum Vaccin Immunother. 2016;12(12):3065-71. [Crossref] [PubMed] [PMC]
- Magon N, Prasad S, Mahato C, Sharma JB. COVID-19 vaccine and pregnancy: a safety weapon against pandemic. Taiwan J Obstet Gynecol. 2022;61(2):201-9. [Crossref] [PubMed] [PMC]
- Martins I, Louwen F, Ayres-de-Campos D, Mahmood T. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur J Obstet Gynecol Reprod Biol. 2021;262:256-8. [Crossref] [PubMed] [PMC]
- Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641-7. [Crossref] [PubMed] [PMC]
- Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. Update in: BMJ. 2022;377:o1205. [PubMed] [PMC]
- ACNM, Fetal Therapy Nurse Network, AWHONN, NPWH, SOGH, Society for Maternal-Fetal Society. Covid-19 vaccination if you are pregnant or breastfeeding. [Cited: January 16, 2023]. Available from: [Link]
- Hayakawa S, Komine-Aizawa S, Takada K, Kimura T, Yamada H. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res. 2021;47(6):1958-64. [Crossref] [PubMed] [PMC]
- Gerberding JL, Haynes BF. Vaccine innovations-past and future. N Engl J Med. 2021;384(5):393-6. [Crossref] [PubMed]
- Demir R, Kaya Odabaş R. A systematic review to determine the anti-vaccination thoughts of pregnant women and the reasons for not getting vaccinated. J Obstet Gynaecol. 2022;42(7):2603-14. [Crossref] [PubMed]
- Hosokawa Y, Okawa S, Hori A, Morisaki N, Takahashi Y, Fujiwara T, et al. The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: an internet-based cross-sectional study in Japan. J Epidemiol. 2022;32(4):188-94. [Crossref] [PubMed] [PMC]
- Erol PÖ, Şahin H, Güvercin CH, Yalçın B, Ocaklı BÖ, Kara H, et al. COVID-19 Aşı Kararsızlığı ve Reddine Sosyolojik Bakış. İzmir: Ege Üniversitesi Yayınları; 2022. [Erişim tarihi: 30.01.2023]. Erişim linki: [Link]
- Tunç SY, Fındık FM, Gül T. COVID-19: gebelik, prenatal bakım ve doğum yönetimi [COVID-19: pregnancy, prenatal care and labour management]. Dicle Med J. 2021;48:70-84. [Crossref]
- Sezerol MA, Davun S. COVID-19 Vaccine hesitancy and related factors among unvaccinated pregnant women during the pandemic period in Turkey. Vaccines (Basel). 2023;11(1):132. [Crossref] [PubMed] [PMC]
- World Health Organization [Internet]. © 2023 WHO. [Cited: January 17, 2023]. The Moderna Covid-19 (mRNA-1273) vaccine: what you need to know. 2021. Available from: [Link]
- Mustafa ZU, Bashir S, Shahid A, Raees I, Salman M, Merchant HA, et al. COVID-19 Vaccine hesitancy among pregnant women attending antenatal clinics in Pakistan: a multicentric, prospective, survey-based study. Viruses. 2022;14(11):2344. [Crossref] [PubMed] [PMC]
- Kilincarslan MG, Sarigul B, Toraman Ç, Şahin EM. Development of valid and reliable scale of vaccine hesitancy in Turkish languag. Konuralp Medical Journal. 2020;12(3):420-9. [Crossref]
- Citu IM, Citu C, Gorun F, Sas I, Bratosin F, Motoc A, et al. The risk of spontaneous abortion does not increase following first trimester mRNA COVID-19 Vaccination. J Clin Med. 2022;11(6):1698. [Crossref] [PubMed] [PMC]
- Egloff C, Couffignal C, Cordier AG, Deruelle P, Sibiude J, Anselem O, et al. Pregnant women's perceptions of the COVID-19 vaccine: A French survey. PLoS One. 2022;17(2):e0263512. [Crossref] [PubMed] [PMC]
- Miraglia Del Giudice G, Folcarelli L, Napoli A, Corea F, Angelillo IF; Collaborative Working Group. COVID-19 vaccination hesitancy and willingness among pregnant women in Italy. Front Public Health. 2022;10:995382. [Crossref] [PubMed] [PMC]
- Schaal NK, Zöllkau J, Hepp P, Fehm T, Hagenbeck C. Pregnant and breastfeeding women's attitudes and fears regarding the COVID-19 vaccination. Arch Gynecol Obstet. 2022;306(2):365-72. [Crossref] [PubMed] [PMC]
- Yoon H, Choi BY, Seong WJ, Cho GJ, Na S, Jung YM, et al. COVID-19 vaccine acceptance during pregnancy and ınfluencing factors in South Korea. J Clin Med. 2022;11(19):5733. [Crossref] [PubMed] [PMC]
- Marbán-Castro E, Nedic I, Ferrari M, Crespo-Mirasol E, Ferrer L, Noya B, et al. Perceptions of COVID-19 maternal vaccination among pregnant women and healthcare workers and factors that influence vaccine acceptance: a cross-sectional study in Barcelona, Spain. Vaccines (Basel). 2022;10(11):1930. [Crossref] [PubMed] [PMC]
- Goncu Ayhan S, Oluklu D, Atalay A, Menekse Beser D, Tanacan A, Moraloglu Tekin O, et al. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet. 2021;154(2):291-6. [Crossref] [PubMed] [PMC]
- Sutton D, D'Alton M, Zhang Y, Kahe K, Cepin A, Goffman D, et al. COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women. Am J Obstet Gynecol MFM. 2021;3(5):100403. [Crossref] [PubMed] [PMC]
- Nguyen LH, Hoang MT, Nguyen LD, Ninh LT, Nguyen HTT, Nguyen AD, et al. Acceptance and willingness to pay for COVID-19 vaccines among pregnant women in Vietnam. Trop Med Int Health. 2021;26(10):1303-13. [Crossref] [PubMed] [PMC]
- Gencer H, Özkan S, Vardar O, Serçekuş P. The effects of the COVID 19 pandemic on vaccine decisions in pregnant women. Women Birth. 2022;35(3):317-23. [Crossref] [PubMed] [PMC]
- Ghamri RA, Othman SS, Alhiniah MH, Alelyani RH, Badawi AM, Alshahrani AA. Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia. Patient prefer adherence. 2022;16:861-73. [Crossref] [PubMed] [PMC]
- Polat G, Sağlam ZA, Polat İ, Yücel B. Gebelikte COVID-19 aşılamasını etkileyen hasta faktörleri: bir anket çalışması [Patients factors affecting COVID-19 vaccination in pregnancy: a survey study]. İKSSTD. 2022;14(2):170-5. [Crossref]
- Rimmer MP, Teh JJ, Mackenzie SC, Al Wattar BH. The risk of miscarriage following COVID-19 vaccination: a systematic review and meta-analysis. Hum Reprod. 2023;38(5):840-52. [Crossref] [PubMed] [PMC]
.: İşlem Listesi